10-Q: SelectQuote Reports Q1 2025 Results, Revenue Up 26% Driven by Pharmacy Growth
Quarterly Report
SelectQuote's first quarter of fiscal year 2025 shows a 26% increase in total revenue, primarily driven by a 61% surge in pharmacy revenue, while the company navigates ongoing financial challenges.
Summary
- SelectQuote's total revenue for the first quarter of fiscal year 2025 increased by 26% to $292.3 million, compared to $232.7 million in the same period last year.
- This growth was largely fueled by a 61% increase in pharmacy revenue, which reached $152.9 million.
- Commissions and other services revenue saw a modest increase of 1% to $139.4 million.
- The company reported a net loss of $44.5 million, or $0.26 per share, compared to a net loss of $31.1 million, or $0.19 per share, in the prior year's quarter.
- Operating costs and expenses totaled $304.2 million, exceeding total revenue, resulting in a loss from operations of $12.0 million.
- The company's cash and cash equivalents decreased to $10.4 million from $42.7 million at the end of the previous quarter.
- SelectQuote has amended its credit agreement multiple times, most recently on October 15, 2024, to extend maturity dates and modify financial covenants.
- The company completed a $100 million securitization transaction on October 15, 2024, to provide advanced financing against expected commission collections.
Sentiment
Score: 4
Explanation: The document presents mixed signals. While revenue growth is positive, the significant net loss, decreasing cash reserves, and ongoing debt restructuring efforts raise concerns. The company's future outlook is uncertain, making it a risky investment at this time.
Positives
- The Healthcare Services segment, particularly SelectRx, is experiencing substantial growth.
- The LTV per approved Medicare Advantage policy has increased, indicating higher potential revenue per sale.
- The company has taken steps to address its debt obligations through a securitization transaction and credit agreement amendments.
Negatives
- The company reported a net loss of $44.5 million, a significant increase from the prior year's loss of $31.1 million.
- Operating costs and expenses exceeded total revenue, resulting in a loss from operations.
- Cash and cash equivalents have decreased significantly, indicating potential liquidity concerns.
- The company has incurred significant interest expenses, totaling $23.0 million for the quarter.
Risks
- The company's ability to maintain compliance with debt covenants is a concern.
- The company may need to secure additional financing or reduce operations if it cannot meet its repayment obligations.
- The company is subject to ongoing legal proceedings, which could be costly to defend and divert management attention.
- The company is reliant on a few major insurance carrier customers, which poses a concentration risk.
Future Outlook
Management expects that existing cash, cash equivalents, funds available under the revolving credit facility, and cash provided from operations will be sufficient to finance normal working capital needs, investments in properties, facilities and equipment, and debt service. The company does not expect to generate sufficient cash flows from operations to enable it to make the milestone payments contemplated in the Eleventh Amendment.
Management Comments
- The company is leveraging its existing customer base and distribution model to improve education and access to healthcare services for senior consumers.
- SelectQuote's value lies in its ability to engage the consumer, capture critical self-reported information in real-time, and then take action on that information to offer each consumer personalized solutions.
- The company continues to look for more opportunities to leverage its strengths to expand its healthcare services business.
Industry Context
The company operates in the direct-to-consumer insurance and healthcare services market, which is experiencing growth due to increasing demand for convenient and personalized solutions. The company's focus on technology-enabled platforms aligns with industry trends towards digital transformation and data-driven decision-making.
Comparison to Industry Standards
- SelectQuote's revenue growth of 26% is notable, but its profitability lags behind some industry peers.
- Companies like eHealth, Inc. also operate in the online health insurance marketplace, but their financial performance and growth rates may differ.
- The company's focus on pharmacy services through SelectRx is a unique aspect compared to some competitors, but it also introduces additional operational complexities.
- The company's debt levels and ongoing need for financing are higher than some industry benchmarks, indicating a higher risk profile.
Legal Proceedings
- The company is involved in a securities class action lawsuit and a stockholder derivative action, both of which are ongoing.
- The company believes that these matters will not have a material adverse effect on its operations, financial condition or liquidity; however, depending on how the matters progress, they could be costly to defend and could divert the attention of management and other resources from operations.
Related Party Transactions
- SelectRx leases the Monaca facility from an Executive Vice President of SelectRx.
Stakeholder Impact
- Shareholders are negatively impacted by the increased net loss and potential dilution from the issuance of warrants.
- Employees may be affected by potential cost-cutting measures or restructuring if the company's financial situation does not improve.
- Customers may benefit from the expansion of healthcare services, but may also be affected by any changes in the company's operations.
- Suppliers and creditors may be concerned about the company's ability to meet its obligations.
Next Steps
- The company will continue to evaluate the realizability of its deferred tax assets.
- The company will continue to look for more opportunities to leverage its strengths to expand its healthcare services business.
- The company will need to secure additional financing or reduce operations if it cannot meet its repayment obligations.
Key Dates
| Date | Description |
|---|---|
| 2019-11-05 | Original Senior Secured Credit Facility entered into. |
| 2021-08-16 | Hartel v. SelectQuote, Inc., et al. securities class action lawsuit filed. |
| 2021-10-07 | West Palm Beach Police Pension Fund v. SelectQuote, Inc., et al. securities class action lawsuit filed. |
| 2022-09-30 | Company terminated its existing interest rate swap indexed to 1-month LIBOR and executed a new interest rate swap indexed to 1-month SOFR. |
| 2023-07-01 | Term Loans are mandatorily repayable in equal quarterly installments of $8.5 million. |
| 2023-09-13 | The fiscal year 2021 tranche of performance stock units vested at 13% of the target. |
| 2024-07-01 | Company realigned its reportable segments for fiscal year 2025. |
| 2024-08-01 | Company entered into four finance leases for equipment with commencement dates August 1, 2024 and September 19, 2024. |
| 2024-09-12 | Tenth Amendment to Senior Secured Credit Facility. |
| 2024-09-30 | End of the quarterly period covered by the report. |
| 2024-10-15 | Company entered into an Eleventh Amendment to its Credit Agreement and completed a $100 million securitization transaction. |
| 2024-10-31 | The registrant had outstanding 171,504,499 shares of common stock. |
Keywords
SelectQuote, pharmacy, revenue, Medicare Advantage, insurance, debt, financial results, healthcare services, commissions, net loss
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.